ES330013A1 - Un procedimiento para componer una preparacion farmaceutica. - Google Patents
Un procedimiento para componer una preparacion farmaceutica.Info
- Publication number
- ES330013A1 ES330013A1 ES0330013A ES330013A ES330013A1 ES 330013 A1 ES330013 A1 ES 330013A1 ES 0330013 A ES0330013 A ES 0330013A ES 330013 A ES330013 A ES 330013A ES 330013 A1 ES330013 A1 ES 330013A1
- Authority
- ES
- Spain
- Prior art keywords
- weight
- adhesive composition
- adhesive
- coating
- core material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 239000000853 adhesive Substances 0.000 abstract 13
- 230000001070 adhesive effect Effects 0.000 abstract 13
- 239000011162 core material Substances 0.000 abstract 11
- 239000000203 mixture Substances 0.000 abstract 9
- 239000003814 drug Substances 0.000 abstract 7
- 239000011248 coating agent Substances 0.000 abstract 5
- 238000000576 coating method Methods 0.000 abstract 5
- 239000002702 enteric coating Substances 0.000 abstract 5
- 238000009505 enteric coating Methods 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 4
- 230000000717 retained effect Effects 0.000 abstract 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 3
- 239000011049 pearl Substances 0.000 abstract 2
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 abstract 1
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 abstract 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 abstract 1
- 229920000084 Gum arabic Polymers 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 229920001800 Shellac Polymers 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 229920002494 Zein Polymers 0.000 abstract 1
- 235000010489 acacia gum Nutrition 0.000 abstract 1
- 239000000205 acacia gum Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000012153 distilled water Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 abstract 1
- 229940113147 shellac Drugs 0.000 abstract 1
- 235000013874 shellac Nutrition 0.000 abstract 1
- 239000004208 shellac Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
- 239000005019 zein Substances 0.000 abstract 1
- 229940093612 zein Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US478437A US3365365A (en) | 1965-08-09 | 1965-08-09 | Repeat action pharmaceutical compositions in the form of discrete beadlets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES330013A1 true ES330013A1 (es) | 1967-06-16 |
Family
ID=23899930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES0330013A Expired ES330013A1 (es) | 1965-08-09 | 1966-08-08 | Un procedimiento para componer una preparacion farmaceutica. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3365365A (enrdf_load_html_response) |
| BE (1) | BE685228A (enrdf_load_html_response) |
| BR (1) | BR6681937D0 (enrdf_load_html_response) |
| ES (1) | ES330013A1 (enrdf_load_html_response) |
| NL (1) | NL6611190A (enrdf_load_html_response) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA959759A (en) * | 1970-01-15 | 1974-12-24 | John J. Miskel | Method for absorption of drugs |
| DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
| US3939259A (en) * | 1974-05-24 | 1976-02-17 | Anthony Pescetti | Coating composition and therapeutic preparation incorporating same |
| US4126672A (en) * | 1976-02-04 | 1978-11-21 | Hoffmann-La Roche Inc. | Sustained release pharmaceutical capsules |
| US4902513A (en) * | 1987-07-31 | 1990-02-20 | Jean Carvais | Oral sustained release medicament |
| EP0343239B1 (en) * | 1987-11-16 | 1993-01-20 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Glassy matrix for administration of beneficial agent |
| US5510115A (en) * | 1987-11-16 | 1996-04-23 | Baxter Travenol Laboratories, Inc. | Method and composition for administration of beneficial agent by controlled dissolution |
| US5599556A (en) * | 1991-12-31 | 1997-02-04 | Abbott Laboratories | Prolamine coatings for taste masking |
| US5328697A (en) * | 1992-02-10 | 1994-07-12 | Mallinckrodt Veterinary, Inc. | Compositions and processes for the sustained release of drugs |
| US5324351A (en) * | 1992-08-13 | 1994-06-28 | Euroceltique | Aqueous dispersions of zein and preparation thereof |
| US5922736A (en) * | 1995-12-04 | 1999-07-13 | Celegene Corporation | Chronic, bolus administration of D-threo methylphenidate |
| US6322819B1 (en) * | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
| WO2001058424A1 (en) * | 2000-02-09 | 2001-08-16 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Floating drug delivery composition |
| US20050239830A1 (en) * | 2004-04-26 | 2005-10-27 | Vikram Khetani | Methods of diminishing co-abuse potential |
| EP2018160B1 (en) | 2006-03-16 | 2011-12-14 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US8846100B2 (en) * | 2006-05-12 | 2014-09-30 | Shire Llc | Controlled dose drug delivery system |
| WO2013003622A1 (en) | 2011-06-28 | 2013-01-03 | Neos Therapeutics, Lp | Dosage forms for oral administration and methods of treatment using the same |
| US12383504B2 (en) | 2012-05-21 | 2025-08-12 | Capsugel Belgium Nv | Acid resistant banding solution for two piece hard capsules |
| CA3018328A1 (en) | 2014-10-31 | 2016-04-30 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| IT201700048797A1 (it) * | 2017-05-05 | 2018-11-05 | Neilos S R L | Sistema di rilascio controllato di ingredienti attivi a base di materiali polimerici e suo impiego in campo nutraceutico. |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3043747A (en) * | 1958-10-22 | 1962-07-10 | Upjohn Co | Tablets coated with carboxymethylcellulose shellac composition |
-
1965
- 1965-08-09 US US478437A patent/US3365365A/en not_active Expired - Lifetime
-
1966
- 1966-08-08 BE BE685228D patent/BE685228A/xx unknown
- 1966-08-08 ES ES0330013A patent/ES330013A1/es not_active Expired
- 1966-08-08 BR BR181937/66A patent/BR6681937D0/pt unknown
- 1966-08-09 NL NL6611190A patent/NL6611190A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL6611190A (enrdf_load_html_response) | 1967-02-10 |
| BR6681937D0 (pt) | 1973-10-25 |
| US3365365A (en) | 1968-01-23 |
| BE685228A (enrdf_load_html_response) | 1967-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES330013A1 (es) | Un procedimiento para componer una preparacion farmaceutica. | |
| DE2336218C3 (de) | Orale Arzneiform | |
| ES303909A1 (es) | Un procedimiento para recubrir una composicion farmaceutica. | |
| JP2620789B2 (ja) | 活性物質の経口投与製剤 | |
| AT327390B (de) | Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen | |
| NO891680D0 (no) | Osmotisk kontinuerlig avgivende oralt avgivelsessystem inneholdende et farmasoeytisk akseptabelt aktivt middel som har forbedrede kjernemembran-adhesjonsegenskaper. | |
| DE69022876D1 (de) | Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe. | |
| NL7610367A (nl) | Aerosolafgeeforgaan voor het afgeven van uniforme doseringen van een fijnverdeeld medicament. | |
| SE402709B (sv) | Forfarande for framstellning av ett farmaceutiskt preparat for behandling av hyperkolesterolemi, innehallande p-klorfenoxiisosmorsyra eller vissa estrar eller salter derav | |
| DE2966564D1 (en) | Therapeutic compositions with enhanced bioavailability and process for their preparation | |
| IL41784A0 (en) | Novel optically active derivatives of 1-phenyl-2-aminoethanol,their preparation and pharmaceutical compositions containing them | |
| FI891774A0 (fi) | Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi | |
| FR2328466A1 (fr) | Nouvelles 4-aminopyrazoles substituees, procede pour leur preparation et medicaments contenant ces composes | |
| ATE77052T1 (de) | Verfahren zur herstellung von etofibrat oder aehnliche verbindungen enthaltende mikrogranula mit verzoegerter freisetzung sowie die auf diese weise erhaltenen produkte. | |
| GB1385285A (en) | Pharmaceutical capsule wall materials | |
| ES2060708T3 (es) | Sistema terapeutico de liberacion retardada para formulaciones farmaceuticas liquidas. | |
| DE2903778C2 (de) | Verwendung von Hydroxypropylmethylcellulose zum Überziehen von den pharmazeutischen Wirkstoff in der Hülle enthaltenden Weichgelatine-Buccalkapseln | |
| GB800973A (en) | Improvements in or relating to pills or tablets | |
| US2333283A (en) | Administration capsule | |
| GB764342A (en) | Improvements in or relating to coated water soluble tablets | |
| IL35841A0 (en) | Pharmaceutical compositions containing quaternary n-isopropyl noratropinium methylate salts,and inhalers for their administration | |
| CA937866A (en) | Process for the manufacture of a drug dosage form permitting controlled release of active ingredient | |
| BE804161A (fr) | Procede de preparation de 3,4-dihydropyridones et medicament contenant ces composes | |
| AT342761B (de) | Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung | |
| BE816071A (fr) | Acides 3-(4-biphenylyl)alcanoiques et medicaments contenant ces composes |